Perspectives of Academic Oncologists About Offering Expanded Access to Investigational Drugs

IMPORTANCE: The expanded access (EA) pathway permits patients to be treated with investigational medical products outside clinical trials. Because cancer care is a common indication for which EA is sought and these efforts require physician management, understanding oncologists' perspectives ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Gould, Patrick, Salam, Tasnim, Kimberly, Laura, Bateman-House, Alison, Fernandez Lynch, Holly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627412/
https://www.ncbi.nlm.nih.gov/pubmed/36318206
http://dx.doi.org/10.1001/jamanetworkopen.2022.39766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627412/
https://www.ncbi.nlm.nih.gov/pubmed/36318206
http://dx.doi.org/10.1001/jamanetworkopen.2022.39766

Ejemplares similares